Related Experiment Video
Updated: Jun 23, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus
Mohammad Javad Mojahedi Mojahedi1, Shokoofeh Bonakdaran, Maryam Hami
1Division of Nephrology, Department of Internal Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Introduction:
Microalbuminuria is a marker of vascular endothelial damage. In addition, it is reported that high serum levels of C-reactive protein (CRP) is a novel cardiovascular risk factor that impairs endothelial function. The aim of this study was to evaluate the relationship between microalbuminuria and elevated serum level of high-sensitivity CRP (HS-CRP) in type 2 diabetic patients.
Materials And Methods:
We measured serum levels of HS-CRP in 87 patients with type 2 diabetes mellitus. They were divided into a microalbuminuric group (n = 45) and those with a 24-hour urine albumin less than 30 mg/d (n = 42). The relationship of serum HS-CRP level with albuminuria and other characteristics of the patients was assessed.
Results:
Patients with microalbuminuria were significantly older and affected by diabetes mellitus longer than those without microalbuminuria. Also, their mean HS-CRP was significantly higher (4.98 +/- 1.45 mg/L versus 2.82 +/- 2.10 mg/L; P < .001). The Pearson correlation test showed a significant correlation between HS-CRP level and urine albumin level (r = 0.43; P < .001). The specificity and sensitivity of HS-CRP for detection of microalbuminuria in were 78.5% and 68.8%, respectively, and the positive and negative predictive values were 77.5% and 70.2%, respectively.
Conclusions:
In type 2 diabetic patients, microalbuminuria is accompanied by elevated HS-CRP, suggesting activation of inflammatory pathways in progression of renal and cardiovascular atherosclerotic disease. As an easier and cheaper test for assessment of diabetic nephropathy, we recommend further studies on HS-CRP in diabetic patients.
Insights
High-sensitivity C-reactive protein (HS-CRP) is elevated in type 2 diabetic patients with microalbuminuria, indicating inflammation linked to kidney and cardiovascular disease progression. HS-CRP may serve as a cost-effective marker for diabetic nephropathy.
Area of Science:
- Endocrinology
- Nephrology
- Cardiology
Background:
- Microalbuminuria signifies vascular endothelial damage in diabetic patients.
- Elevated C-reactive protein (CRP) is a recognized cardiovascular risk factor impacting endothelial function.
- High-sensitivity CRP (HS-CRP) is investigated for its role in diabetic complications.
Purpose of the Study:
- To investigate the association between microalbuminuria and serum HS-CRP levels in type 2 diabetes mellitus.
- To assess HS-CRP as a potential indicator of endothelial dysfunction and inflammation in diabetic nephropathy.
Main Methods:
- Serum HS-CRP levels were measured in 87 type 2 diabetic patients.
- Patients were categorized into microalbuminuric and normoalbuminuric groups.
- Statistical analyses, including Pearson correlation, assessed the relationship between HS-CRP, albuminuria, and patient characteristics.
Main Results:
- Microalbuminuric patients were older and had longer diabetes duration.
- Mean serum HS-CRP levels were significantly higher in the microalbuminuric group (4.98 mg/L vs. 2.82 mg/L).
- A significant positive correlation was found between HS-CRP and urine albumin levels (r = 0.43).
Conclusions:
- Elevated HS-CRP in microalbuminuric type 2 diabetic patients suggests activated inflammatory pathways.
- This inflammation may contribute to the progression of renal and cardiovascular atherosclerotic disease.
- HS-CRP shows potential as an accessible and economical marker for assessing diabetic nephropathy, warranting further research.
Related Concept Videos
Diabetic Nephropathy
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes Mellitus: Type 2 and Gestational
Diabetic Retinopathy
Type I Diabetes III: Clinical Manifestations
Type II Diabetes II: Pathophysiology